Virus Dissemination Through the Brain Parenchyma Without Immunologic Control

Journal of Immunology

Volumn 159, Issue 4, 1997, Pages 1876-1884

  Stevenson, Philip G ^a,b   Freeman, Samantha ^a   Bangham, Charles R M ^a,c   Hawke, Simon ^a,d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANIMAL; ARTICLE; BLOOD; BRAIN; C57BL MOUSE; IMMUNIZATION; IMMUNOLOGY; IMMUNOPHENOTYPING; MOUSE; ORTHOMYXOVIRUS INFECTION; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BRAIN; IMMUNIZATION; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTES;

EID: 0031571231     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Johnson, R. T. 1982. Viral Infections of the Nervous System. Raven Press, New York.
2. Griffin, D. E., B. Levine, S. Ubol, and J. M. Hardwick. 1994. The effects of alphavirus infection on neurons. Ann. Neurol. 35:S23.
3. Brent, L. 1990. Immunologically privileged sites. In Pathophysiology of the Blood-Brain Barrier. B. B. Johansson, C. Owman, and H. Widner, eds. Elsevier, Oxford, U.K., p. 383.
4. Medawar, P. B. 1948. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to the anterior chamber of the eye. Brit. J. Exp. Pathol. 29:58.
5. Cserr, H. F., and P. M. Knopf. 1992. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 13:507.
6. Gordon, L. B., P. M. Knopf, and H. F. Cserr. 1992. Ovalbumin is more immunogenic when introduced into brain or cerebrospinal fluid than into extracerebral sites. J. Neuroimmunol. 40:81.
7. Hart, D. N. J., and J. W. Fabre. 1981. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, hut not brain. J. Exp. Med. 153:347.
8. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
9. 8a. Griffin, D. E. 1981. Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice. J. Immunol. 126:27.
10. Lynch, F., P. C. Doherty, and R. Ceredig. 1989. Phenotypic and functional analysis of the cellular response in regional lymphoid tissue during an acute virus infection. J. Immunol. 142:3592.
11. Stevenson, P. G., S. Hawke, D. J. Sloan, and C. R. M. Bangham. 1997. The immunogenicity of intracerebral virus infection depends upon anatomical site. J. Virol. 71:145.
12. Ravenholt, R. T., and W. H. Foege. 1982. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 2:860.
13. Yolken, R. H., and E. F. Torrey. 1995. Viruses, schizophrenia and bipolar disorder. Clin. Microbiol. Rev. 8:131.
14. Webster, R. G., W. G. Laver, G. M. Air, and G. C. Schild. 1982. Molecular mechanisms of variation in influenza viruses. Nature 296:115.
15. Stuart-Harris, C. H. 1939. A neurotropic strain of human influenza virus. Lancet 1:497.
16. Takahashi, M., T. Yamada, S. Nakajima, K. Nakajima, T. Yamamoto, and H. Okada. 1995. The substantia nigra is a major target for neurovirulent influenza A virus. J. Exp. Med. 181:2161.
17. Li, S., J. Schulman, S. Itamura, and P. Palese. 1993. Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J. Virol. 67:6667.
18. Sugiura, A., and M. Ueda. 1980. Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains. Virology 101:440.
19. Schlesinger, R. W., G. L. Bradshaw, F. Barbone, M. Reinacher, R. Rott, and P. Husak. 1989. Role of haemagglutinin cleavage and expression of M1 protein in replication of A/WS/33, A/PR/8/34 and WSN influenza viruses in mouse brain. J. Virol. 63:1695.
20. Wyde, P. R., B. E. Gilbert, and B. M. Levy. 1983. Evidence that T-lymphocytes are part of the blood-brain barrier to virus dissemination. J. Neuroimmunol. 5:47.
21. Mims, C. A. 1959. Intracerebral injections and the growth of viruses in the mouse brain. Br. J. Exp. Pathol. 41:52.
22. Barrett, T., and S. C. Inglis. 1985. Growth and purification of influenza virus. In Virology - A Practical Approach. B. W. J. Mahy, ed. IRL Press, Oxford, U.K., p. 119.
23. Taylor, P. M., D. B. Thomas, and K. H. G. Mills. 1987. In vitro culture of T cell lines and clones. In Lymphocytes - A Practical Approach G. G. B. Klaus, ed. IRL Press, Oxford, U.K., p. 133.
24. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognised by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
25. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecules involved in organ-specific homing of lymphocytes. Nature 304:30.
26. Trowbridge, I. S., J. Lesley, R. Schulte, R. Hyman, and J. Trotter. 1982. Biochemical characterisation and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid cells. Immunogenetics 15:299.
27. Miyake, K., I. L. Weissman, J. S. Greenberger, and P. W. Kincade. 1991. Evidence for a role of the integrin VLA-4 in lymphohemopoiesis. J. Exp. Med. 173:599.
28. Cobbold, S. P., A. Jaysuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T cell subsets in vivo. Nature 312:548.
29. Wilde, D. B., P. Marrack, J. Kappler, D. P. Dialynas, and F. W. Fitch. 1983. Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J. Immunol. 131:2178.
30. Stallcup, K. C., T. A. Springer, and M. F. Mescher. 1981. Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. J. Immunol. 127:923.
31. Germain, R. N., A. Bhattacharya, M. E. Dorf, and T. A. Springer. 1982. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2I subregions. J. Immunol. 128:1409.
32. Reinacher, M., J. Bonin, O. Narayan, and C. Scholtissek. 1983. Pathogenesis of neurovirulent influenza A virus infection in mice. Lab. Invest. 49:686.
33. Engelhardt, B., F. K. Conley, P. J. Kilshaw, and E. C. Butcher. 1995. Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int. Immunol. 7:481.
34. Springer, T., G. Galfre, D. S. Secher, and C. Milstein. 1979. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:301.
35. Tyrrell, D. A. J., and A. H. Cameron. 1957. The pathogenicity of influenza viruses for suckling mice. J. Pathol. Bacteriol. LXXIV:37.
36. Hinshaw, V. S., C. W. Olsen, N. Dybdahl-Sissoko, and D. Evans. 1994. Apoptosis: a mechanism of cell killing by influenza A and B viruses. J. Virol. 68:3667.
37. Olsen, C. W., J. C. Kehren, N. R. Dybdahl-Sissoko, and V. S. Hinshaw. 1996. bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J. Virol. 70:663.
38. Wekerle, H., C. Linnington, H. Lassmann, and R. Meyermann. 1986. Cellular immune reactivity within the CNS. Trends Neurosci. 6:271.
39. Ludowyk, P. A., D. O. Willenborg, and C. R. Parish. 1992. Selective localisation of neuro-specific T lymphocytes in the central nervous system. J. Neuroimmunol. 37:237.
40. Barten, D. M., R. B. Clark, and N. H. Ruddle. 1995. Presence of T cells with activated and memory phenotypes in inflammatory spinal cord lesions. J. Immunol. 155:5409.
41. Budd, R. C., J-C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. MacDonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138:3120.
42. + memory T cells. J. Immunol. 154:5870.
43. + memory T cells. J. Immunol. 157:3065.
44. Selmaj, K. W., and C. S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339.
45. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947.